Evidence Based Benzodiazepine Tapering: 2025 ASAM Guidelines in Practice

INTRODUCTION VIDEO:

COURSE INFORMATION:

Join us for a structured course designed to equip you with the most current, evidence-based approaches to benzodiazepine tapering—based on the newly released 2025 ASAM Clinical Practice Guideline. Whether you’re supporting patients with long-term benzodiazepine use, navigating challenging withdrawal symptoms, or balancing risk-benefit decisions, this course will provide the tools and clarity you need.

Course Modules (total = 2 hours):

  1. Session 1: Clinical Foundations of BZD Tapering (35 min)
  2. Session 2: Designing & Monitoring the Taper (30 min)
  3. Session 3: Adjunctive Strategies & Complication Management (15 min)
  4. Session 4: Special Populations & Complex Clinical Scenarios (35 min)

Who Should Enroll?

  1. Psychiatrists & Primary Care Physicians
  2. Nurse Practitioners & Physician Assistants
  3. Pharmacists
  4. Any medical professional involved in BZD prescribing or tapering

Here’s a slide from the course that outlines how to assess dependence status in patients on chronic benzodiazepine therapy.

tapering vs discontinuation:
assess dependence status

COURSE PRICING:

Non-Member Access

Enroll Now

Academy-Member Access

Academy Members: You are automatically enrolled in this course as part of your membership—no need to subscribe separately.

Scroll Down to Begin Course

TABLE OF CONTENT:

Responses

Your email address will not be published. Required fields are marked *